Skip to main content
. 2021 Aug 31;10(9):849. doi: 10.3390/biology10090849
A549 Adenocarcinomic human alveolar basal epithelial cells
ABL Tyrosine-protein kinase transforming protein Abl
ABCB1/Flp-In-293 Fetal kidney cell line stably expressing P-gp
ABVD Chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine
BCR Breakpoint cluster region protein (renal carcinoma antigen NY-REN-26)
BEACOPP Chemotherapy combination of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisolone
CHOP Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone
CNS Central nervous system
CVD Chemotherapy with cyclophosphamide, vincristine, and dacarbazine
DNA Deoxyribonucleic acid
Eca109/VCR Human cells from esophageal cancer
EPOCH-(R) Combination therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab, and etoposide
EMA Chemotherapy combination of methotrexate, etoposide, and dactinomy-cin
EMA/CO Chemotherapy combination of etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine
FDA US Food and Drug Administration
G401 Human cells from a rhabdoid tumor of the kidney
IC50 Half-maximal inhibitory concentration
IDH1/2 Gene encoding nicotinamide adenine dinucleotide phosphate-dependent isocitrate dehydrogenases
IL-1 Interleukin 1 receptor
KB-V Cervical adenocarcinoma cell line
LGG Low-grade gliomas
LC3-I Microtubule-associated proteins 1A/1B light chain 3B
lncRNA Long non-coding RNA
MCF-7/ADR Multidrug-resistant breast cancer cell line
MEG3 Maternally expressed gene 3
MOPP Combination of vincristine, procarbazine, prednisone, and mechlorethamine
NHP2L1 Non-histone protein 2-like protein 1
NOXA Gene coding phorbol-12-myristate-13-acetate-induced protein 1
PCNSL Primary central nervous system lymphoma
PCV Chemotherapy combination of procarbazine, lomustine, and vincristine
P-gp P-glycoprotein
PMAIP1 Gene encoding phorbol-12-myristate-13-acetate-induced protein 1
R-CHOP Combination therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab
R-CHOPE Combination therapy with cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab, and etoposide
RNA Ribonucleic acid
VIPN Vincristine-induced peripheral neuropathy
WERI-Rb-1 Human cells from retinoblastoma
XIST X-inactive specific transcript
Y79 Human cells from retinoblastoma